Literature DB >> 21596842

Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations.

Kirk Cunningham1, Yutaka Uchida, Erin O'Donnell, Estefania Claudio, Wenling Li, Kosha Soneji, Hongshan Wang, Yoh-suke Mukouyama, Ulrich Siebenlist.   

Abstract

Cerebral cavernous malformations (CCM) are irregularly shaped and enlarged capillaries in the brain that are prone to hemorrhage, resulting in headaches, seizures, strokes and even death in patients. The disease affects up to 0.5% of the population and the inherited form has been linked to mutations in one of three genetic loci, CCM1, CCM2 and CCM3. To understand the pathophysiology underlying the vascular lesions in CCM, it is critical to develop a reproducible mouse genetic model of this disease. Here, we report that limited conditional ablation of Ccm2 in young adult mice induces observable neurological dysfunction and reproducibly results in brain hemorrhages whose appearance is highly reminiscent of the lesions observed in human CCM patients. We first demonstrate that conventional or endothelial-specific deletion of Ccm2 leads to fatal cardiovascular defects during embryogenesis, including insufficient vascular lumen formation as well as defective arteriogenesis and heart malformation. These findings confirm and extend prior studies. We then demonstrate that the inducible deletion of Ccm2 in adult mice recapitulates the CCM-like brain lesions in humans; the lesions display disrupted vascular lumens, enlarged capillary cavities, loss of proper neuro-vascular associations and an inflammatory reaction. The CCM lesions also exhibit damaged neuronal architecture, the likely cause of neurologic defects, such as ataxia and seizure. These mice represent the first CCM2 animal model for CCM and should provide the means to elucidate disease mechanisms and evaluate therapeutic strategies for human CCM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596842      PMCID: PMC3140822          DOI: 10.1093/hmg/ddr225

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

1.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

Authors:  Y Y Kisanuki; R E Hammer; J Miyazaki ; S C Williams; J A Richardson; M Yanagisawa
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

2.  Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.

Authors:  Mark T Uhlik; Amy N Abell; Nancy L Johnson; Weiyong Sun; Bruce D Cuevas; Katherine E Lobel-Rice; Eric A Horne; Mark L Dell'Acqua; Gary L Johnson
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

3.  Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Authors:  Angeliki Louvi; Leiling Chen; Aimee M Two; Haifeng Zhang; Wang Min; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

4.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.

Authors:  Masaaki Hayashi; Sung-Woo Kim; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; E Dale Abel; Brian Eliceiri; Young Yang; Richard J Ulevitch; Jiing-Dwan Lee
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.

Authors:  Kevin J Whitehead; Nicholas W Plummer; Jennifer A Adams; Douglas A Marchuk; Dean Y Li
Journal:  Development       Date:  2004-03       Impact factor: 6.868

6.  sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation.

Authors:  Nathan D Lawson; Andreas M Vogel; Brant M Weinstein
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

7.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

8.  Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice.

Authors:  André Schneider; Yahua Zhang; Youfei Guan; Linda S Davis; Matthew D Breyer
Journal:  Am J Physiol Renal Physiol       Date:  2002-10-22

9.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

10.  Notch signaling is required for arterial-venous differentiation during embryonic vascular development.

Authors:  N D Lawson; N Scheer; V N Pham; C H Kim; A B Chitnis; J A Campos-Ortega; B M Weinstein
Journal:  Development       Date:  2001-10       Impact factor: 6.868

View more
  21 in total

Review 1.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

Review 2.  Endothelial cell-cell adhesion during zebrafish vascular development.

Authors:  Anne K Lagendijk; Alpha S Yap; Benjamin M Hogan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 3.  STRIPAK complexes: structure, biological function, and involvement in human diseases.

Authors:  Juyeon Hwang; David C Pallas
Journal:  Int J Biochem Cell Biol       Date:  2013-12-11       Impact factor: 5.085

Review 4.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

Review 5.  Cerebral cavernous malformation proteins at a glance.

Authors:  Kyle M Draheim; Oriana S Fisher; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2014-01-30       Impact factor: 5.285

6.  CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.

Authors:  Lingfeng Qin; Haifeng Zhang; Busu Li; Quan Jiang; Francesc Lopez; Wang Min; Jenny Huanjiao Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

Review 7.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

8.  Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke.

Authors:  Christine Weinl; Salvador Castaneda Vega; Heidemarie Riehle; Christine Stritt; Carsten Calaminus; Hartwig Wolburg; Susanne Mauel; Angele Breithaupt; Achim D Gruber; Bohdan Wasylyk; Eric N Olson; Ralf H Adams; Bernd J Pichler; Alfred Nordheim
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-28       Impact factor: 11.205

Review 9.  Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction.

Authors:  Magdalena Chrzanowska-Wodnicka
Journal:  Exp Cell Res       Date:  2013-08-02       Impact factor: 3.905

10.  Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice.

Authors:  Gwénola Boulday; Noemi Rudini; Luigi Maddaluno; Anne Blécon; Minh Arnould; Alain Gaudric; Françoise Chapon; Ralf H Adams; Elisabetta Dejana; Elisabeth Tournier-Lasserve
Journal:  J Exp Med       Date:  2011-08-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.